Medical Device News Magazine

What do the upcoming trends in medical devices look like? In the fast-changing healthcare sector, keeping up-to-date with the newest developments in medical technology is crucial for experts and enthusiasts. Medical Device News Magazine is a crucial source of information, providing valuable perspectives on state-of-the-art innovations, regulatory changes, FDA updates on medical devices, and industry trends affecting patient care and business approaches. Our goal is to connect healthcare professionals, investors, and the medical device industry by offering breaking news and articles authored by experts in this space. Medical Device News Magazine aims to stimulate discussions on advancements in medical devices and biotechnology, and their impact on the future of medicine.

Featuring Medical Devices/Biotechnology Updates

NEC Corporation Has Developed Technologies that Enable a Secure Workflow for Personalized Cancer Vaccines & Has Proven their Capabilities

April 1, 20250

This initiative marks a world-first accomplishment that is aligned with the practical workflow expected for personalized cancer vaccine therapies

CorVista Health Presents New Data on Non-Invasive Point of Care Testing for Pulmonary Capillary Wedge Pressure (PCWP) Elevation Using Machine Learning

March 31, 20250

The poster titled ‘Point-of-Care Testing for Pulmonary Capillary Wedge Pressure Elevation Using Machine Learning on Non-invasive Signals’ was presented at the American College of Cardiology’s Annual Scientific Session (ACC.25) in Chicago on March 30, 2025.

MedCognition Announces Extended Reality (XR) Medical Simulation Training Technology Receives Broad Method Patent from USPTO

March 19, 20250

Integrated within the company’s PerSim® medical education and training platform, the patented XR-based technology increases training efficacy by providing a safe and controlled environment that closely resembles authentic patient encounters, allowing students to refine their clinical skills and improve preparedness through real-world scenario simulations.

Industry Expert Byline

The Dangers of Undiagnosed Sleep Apnea: How At-Home Diagnostics Is Revolutionizing Detection and Enabling Life-Saving Treatment

March 24, 2025

Discover how at-home diagnostics are transforming the detection of undiagnosed sleep apnea and enabling essential treatments.

Luxembourg Institute of Health (LIH) and Cytovation AS Advance New Cancer Therapy Towards Clinical Success

April 1, 2025 0

Discover how the Luxembourg Institute of Health propels CY-101 toward clinical success in cancer treatment advancements.

Sphere Bio Launches Cyto-Cellect Human IgG Kappa and Viability Assay Kit for Efficient Single-cell Selection

March 31, 2025 0

Sphere Bio, a leading provider of innovative picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, today announced the launch of the Cyto-Cellect® Human IgG Kappa and Viability Assay Kit, the first multiplexed assay developed specifically for the Company’s new Cyto-Mine® Chroma platform. The Cyto-Mine Chroma platform uses fluorescence-based assays in picodroplets to select single cells based on secreted, surface, and/or intracellular markers. Aided by the new multiplexing capability of the Chroma system, the Cyto-Cellect Human IgG Kappa and Viability Assay Kit represents a significant advancement enabling researchers to complete...

RenyMed Earns Prestigious EcoVadis Gold Medal for Excellence in Sustainability

March 19, 2025 0

This achievement places RenyMed in the top 5% of all companies assessed globally, underscoring its dedication to ethical business practices, environmental stewardship, and workforce well-being.

FDA Updates

April 1, 20250

This milestone marks a significant achievement in expanding restor3d’s knee replacement technology since the acquisition of Conformis, introducing the first cementless offering to the patient-specific implant portfolio. The company plans a limited market release in Q3 of 2025.

restor3d Receives FDA Clearance for iTotal IdentityTM CR 3DP Porous Fully Personalized Total Knee Replacement System

March 6, 20250

"Receiving both of these certified designations from the FDA is a tremendous validation of our work," said Dr. Connor Glass, Founder and CEO of Phantom Neuro. "These recognitions validate our technology and reflect our commitment to creating scalable, real-world solutions that restore functionality and independence to amputees and those with functional disabilities. Our goal is to bring Phantom X to patients faster, and achievements like this accelerate our clinical and regulatory processes."

Phantom Neuro Receives FDA Breakthrough Device & TAP Designations, Solidifying Position as a Neurotech Leader

Clinical Trials and Updates

Franco Cavaleri Challenges Conventional Alzheimer’s Theories in Groundbreaking Study

April 1, 2025

This research, featured in Frontiers in Neuroscience, proposes a paradigm shift in understanding the function of Aβ, suggesting they may serve a protective role against metal toxicity in the brain rather than being primary culprits in AD progression.

Precision Study Underway – 100 Prostate Cancer Patients Treated in Just 3 Radiation Sessions

March 27, 2025

"The goal of the Precision Study is to ensure that treatment with three radiation doses does not lead to greater side effects than those observed in the Pace-B study. I am confident that we can demonstrate effective cancer treatment with less side effects," says Professor McLaren.

Expert Bylines

The Dangers of Undiagnosed Sleep Apnea: How At-Home Diagnostics Is Revolutionizing Detection and Enabling Life-Saving Treatment

Discover how at-home diagnostics are transforming the detection of undiagnosed sleep apnea and enabling essential treatments.

A New Future for PTSD Treatment: Drug-Free, Trauma-Free, Brain-Powered

Explore groundbreaking PTSD treatment options that are drug-free and trauma-free, offering hope for recovery through advanced medical devices.

Acquisitions /Mergers

Market Reports

Funding

Boston Scientific Reveals Agreement to Acquire SoniVie Ltd.

Medical Device News Magazine - March 3, 2025

"Renal denervation for hypertension is an exciting medical advancement for the millions of patients it may help and is supported by positive results from contemporary clinical trials and ongoing research," said Lance Bates, senior vice president and president, Interventional Cardiology Therapies, Boston Scientific. "We believe the addition of the differentiated, ultrasound-based TIVUS system can complement our expansive interventional portfolio with a minimally invasive therapy for patients with hypertension and provides opportunity for future advancements in this space."

Plant Biotechnology Market worth $76.79 billion by 2030

Medical Device News Magazine - April 1, 2025

The plant biotechnology market is estimated at USD 51.73 billion in 2025 and is projected to reach USD...

CRDMO Market Outlook & Forecasts 2024-2029: Increase in Transaction to Build CRDMOs, Demand for Outsourcing, Integration of Advanced Technologies – ResearchAndMarkets.com

Medical Device News Magazine - March 19, 2025

The CRDMO Market was valued at USD 196.14 billion in 2023, and is projected to reach USD 328.90 billion by 2029, rising at a CAGR of 9.00%.

Exciting Times Ahead for TRIMTECH Therapeutics with $31M Seed Funding

Medical Device News Magazine - March 5, 2025

The investment will support further development of TRIMTECH Therapeutics growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader molecules known as TRIMTACs. The pipeline is focused around the development of treatments for severe neurodegenerative and inflammatory disorders, including Alzheimer’s and Huntington’s disease.

Executives on the Move

InfuSystem Announces CEO Transition | Carrie Lachance to Become CEO Effective May 19, 2025

April 1, 2025

“Carrie Lachance has been at the center of InfuSystem’s succession plan for the past several years, and she is the ideal person to succeed Rich DiIorio having spent the last decade plus working her way up through ever greater positions of responsibility within the Company,” said Scott Shuda, Chairman of the board of InfuSystem.

ITM Appoints Dr. Celine Wilke Chief Medical Officer

April 1, 2025

“Celine brings a wealth of experience in advancing radiopharmaceutical precision oncology treatments from early development through to regulatory approval. As she steps into the leadership of our medical team, her expertise will be instrumental in progressing our pipeline and delivering new treatment options for patients,” said Dr. Andrew Cavey, Chief Executive Officer of ITM.

Nuage Therapeutics Appoints Dr. Stuart Hughes CEO and Vanessa Malier as Chair

April 1, 2025

Nuage Therapeutics applying its proprietary technology to advance a pipeline of novel agents targeting oncogenic transcription factors.

Olga Uspenskaya-Cadoz Appointed Chief Medical Officer of VectorY Therapeutics

April 1, 2025

Dr. Uspenskaya-Cadoz brings two decades of experience in neurology, gene therapy, and clinical development, enhancing VectorY’s leadership in developing transformative treatments for neurodegenerative conditions.

Operation Warp Speed Leader Tapped as Panther Life Sciences’ New R&D Chief | The Appointment of Dr Matthew Hepburn to Expand Panther’s Leadership For Next Generation Immune-Mediated Therapies

March 27, 2025

In this role, Dr Martin Hepburn will drive Panther’s strategic commitment to commercialize its patented MAP technology, with a primary focus on reducing time-to-market and delivering the first commercial product to customers within the next two years.

Michael Andersen Joins Vektor Medical as Vice President, Quality Assurance and Regulatory Affairs

March 17, 2025

Michael Andersen brings more than 20 years of commercial leadership experience in electrophysiology and medtech, with a strong track record of market development, sales execution, and strategic growth.

Hospitals in the News

Delray Medical Center Notes Vascular Surgeon Dr Joseph Ricotta 1st in the World to Utilize the Celt ACD PLUS System In a Procedure

March 27, 2025 0

“The Celt ACD PLUS is another surgical option for patients, ensuring that they have the best chance of a good outcome,” said Dr. Ricotta. “By investing in the latest medical technology, we remain at the forefront of innovation as medicine continues to advance.” Dr. Ricotta is the National Medical Director of Vascular Surgery and Endovascular Therapy for Tenet Healthcare, and Professor of Surgery and Founder and Program Director of the Vascular Surgery at Florida Atlantic University’s School of Medicine.

Join Our Family of Advertisers

Advertise with Medical Device News Magazine! Increase Your Visibility

February 5, 2025 0

Ignite Your Brand! Advertise with Medical Device News Magazine. We pride ourselves on being the best-kept secret when it comes to distributing your news! Our...

Non Profit Happenings

Header Restriction Policy in Youth Soccer Shows Promising Impact on Concussion Rates

Medical Device News Magazine - March 10, 2025

Researchers found that the policy was associated with a decrease in soccer-related concussions; however, female players experienced a higher proportion of concussions than their male counterparts.

Health / Lifestyle

Transforming Orthodontic Care with Advanced Technology

March 27, 20250

Explore how cutting-edge technologies are reshaping orthodontics, enhancing patient experiences, and improving treatment outcomes. Innovative tools and techniques are redefining traditional approaches, offering new...

Cellular Degeneration: What Science Is Telling Us So Far

March 24, 20250

Cellular degeneration—the gradual deterioration of cells that contributes to aging and disease—has become a central focus of modern medical research. As our understanding of...

Ivy Fertility Physicians & Experts Launch Podcasts

March 19, 20250

These podcasts offer valuable insights into the fertility journey, empowering patients with knowledge and support from some of the industry’s most trusted voices.

Medical Device News MagazineA Publication for the Practicing Medical Specialist, Industry Executive & Investor